Cargando…
Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report
Rapidly progressive interstitial lung disease is typically associated with clinically amyopathic dermatomyositis and the anti-melanoma differentiation associated gene 5 antibody, a condition with high mortality and resistance to classic immunosuppression. Recent reports have described the efficacy o...
Autores principales: | Conca, Walter, Weheba, Ihab, Abouzied, Mohei-Eldin, Abdelsayed, Abeer, Aleyouni, Yousif, Al‐Mutairy, Eid, Bakshi, Nasir, Khalid, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770219/ https://www.ncbi.nlm.nih.gov/pubmed/33384600 http://dx.doi.org/10.3389/fphar.2020.585761 |
Ejemplares similares
-
Clinical-grade Computational Pathology: Alea Iacta Est
por: Fraggetta, Filippo
Publicado: (2019) -
Clinical outcome and survival in 30 pulmonary hypertension patients with high severity indices and advanced functional class
por: Khalid, Mohammed, et al.
Publicado: (2019) -
Superior vena cava stenting in IgG4-associated mediastinal fibrosis
por: Khalid, Mohammed, et al.
Publicado: (2020) -
Le cours du temps est-il inexorable?
por: Jacob, Maurice René Michel
Publicado: (1997) -
Neuroprotective effect of Neuro-EPO in neurodegenerative diseases: “Alea jacta est”
por: Rama, Ramón, et al.
Publicado: (2019)